Replies to post #243486 on Biotech Values

[DewDiligence]

INDV.L acquires OPNT for $20/sh cash—a 111% premium to Friday’s close:

https://www.globenewswire.com/news-release/2022/11/14/2554546/0/en/Indivior-PLC-to-Acquire-Opiant-Pharmaceuticals.html

The deal includes a non-tradeable CVR worth as much as $8/sh. The nominal deal value (excluding the CVR) is ~$110M.